ImmunoGen
IMGN
#1877
Rank
NZ$14.71 B
Marketcap
$52.69
Share price
0.00%
Change (1 day)
132.81%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: NZ$14.71 Billion

On April 12, 2024 ImmunoGen had a market cap of NZ$14.71 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$14.71 B17.29%
2023NZ$12.54 B627.68%
2022NZ$1.72 B-27.87%
2021NZ$2.39 B37.37%
2020NZ$1.74 B52.94%
2019NZ$1.13 B6.45%
2018NZ$1.06 B-10.43%
2017NZ$1.19 B364.26%
2016NZ$0.25 B-85.1%
2015NZ$1.72 B157.51%
2014NZ$0.67 B-56.16%
2013NZ$1.52 B17.15%
2012NZ$1.30 B15.05%
2011NZ$1.13 B38.9%
2010NZ$0.81 B31.65%
2009NZ$0.62 B65.17%
2008NZ$0.37 B61.55%
2007NZ$0.23 B-22.44%
2006NZ$0.29 B-2.81%
2005NZ$0.30 B-39.04%
2004NZ$0.50 B60.4%
2003NZ$0.31 B26.15%
2002NZ$0.24 B-84.26%
2001NZ$1.58 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$72.81 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$271.02 B 1,741.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.311 T 8,810.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$201.96 B 1,272.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$620.04 B 4,112.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$250.41 B 1,601.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$353.91 B 2,304.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$216.84 B 1,373.18%๐Ÿ‡ซ๐Ÿ‡ท France